Lu, Maolin
Ma, Xiaochu
Castillo-Menendez, Luis R.
Gorman, Jason
Alsahafi, Nirmin
Ermel, Utz
Terry, Daniel S.
Chambers, Michael
Peng, Dongjun
Zhang, Baoshan
Zhou, Tongqing
Reichard, Nick
Wang, Kevin
Grover, Jonathan R.
Carman, Brennan P.
Gardner, Matthew R.
Nikić-Spiegel, Ivana
Sugawara, Akihiro
Arthos, James
Lemke, Edward A.
Smith, Amos B. III
Farzan, Michael
Abrams, Cameron
Munro, James B.
McDermott, Adrian B.
Finzi, Andrés
Kwong, Peter D.
Blanchard, Scott C.
Sodroski, Joseph G.
Mothes, Walther
Article History
Received: 31 December 2017
Accepted: 8 March 2019
First Online: 10 April 2019
Competing interests
: S.C.B. holds an equity interest in Lumidyne Technologies. M.F. is a co-founder of Emmune, a company developing eCD4-Ig for clinical use. E.A.L. holds the patent WO 2012/104422 A1. S.C.B., J.B.M. and W.M. hold the patent US 959385324 B2.